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ABSTRACT 
 
 
Introduction: Recent studies suggest the potential role that foreign bodies play in 
the pathogenesis of implant failure. The aims of this investigation are: (1) to evaluate the 
presence of foreign bodies in proximity to failing dental implants that have been 
removed; (2) to examine the effect that these foreign bodies have on the surrounding 
hard and soft tissues. 
Materials and Methods: A total of 21 patients possessing 34 dental implants were 
enrolled in this prospective, cross-sectional ex vivo study. Five of these 34 implants were 
removed for restorative reasons and were used as positive controls. A total of 6 implants 
(5 failed, 1 control) were assigned to group E (enzymatic digestion) and 28 implants (23 
failed, 5 control) were assigned to group GS (ground section). Group E implants 
underwent enzymatic digestion in collagenase/dispase. Foreign bodies were isolated and 
imaged using Scanning Electron Microscopy (SEM) and Energy Dispersive X-ray 
Spectroscopy (EDS). Group GS implants were ground to 100 µm thick sections. 
Specimens were imaged using light microscopy, SEM, and EDS. 
Results: One patient dropped out prior to implant removal, resulting in 33 total 
implants. Group E specimens primarily contained organic elements and minerals 
(carbon, oxygen, nitrogen, calcium, phosphorus, sodium, and chloride). Zinc was found 
in select specimens. Light microscopy of group GS revealed a greater number and size 
of titanium particles associated with failed implants. Titanium particles were commonly 
observed in proximity to soft tissue, demineralized bone, and inflammatory cells. Failed 
implants displayed surface delamination and bacterial colonies with accompanying 
titanium particles. Titanium particles were observed near the lumen of intrabony blood 
vessels in both failed and control implants. SEM and EDS of failed implants revealed 
countless titanium particles exfoliated from the implant surface. EDS of positive controls 
revealed the presence of titanium within the bone-implant interface. 
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Conclusion: A greater number and size of titanium particles are associated with 
failed implants when compared to controls. Titanium particles are correlated with 
bacteria, inflammation, implant surface delamination, and local vasculature. Implant 
surface distortion and titanium exfoliation may produce an environment that is not 
compatible with health. 
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NOMENCLATURE 
 
PMN Polymorphonuclear leukocyte 
RANKL Receptor activator of nuclear factor kappa-B ligand 
RANK Receptor activator of nuclear factor kappa-B 
AGE Advanced glycation end product 
BRONJ Bisphosphonate related osteonecrosis of the jaw 
MRONJ Medication related osteonecrosis of the jaw 
IL Interleukin 
TNF-a Tumor necrosis factor-alpha 
PDL Periodontal ligament 
TiO2 Titanium Dioxide layer 
CO2 Carbon Dioxide 
SEM Scanning Electron Microscopy 
Group E Enzymatic digestion specimens 
Group GS Ground Section specimens 
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1. INTRODUCTION AND LITERATURE REVIEW 
 
Background and Significance 
 
The field of dentistry and oral health has dramatically improved and evolved over the 
past few decades. According to the Centers for Disease Control and Prevention, the 
number of United States adults with complete tooth loss has decreased from 49 percent 
in 1960 to 13 percent in 2012.1, 2 Additionally, elderly adults are motivated to maintain 
their dentition since tooth loss has an impact on their oral health-related quality of life.3 
Some benefits to having a full complement of teeth include improved esthetics, function, 
nutrient intake, and self-esteem. The number of people that are keeping their teeth is on 
the rise and when patients are missing certain teeth, they often choose to have them 
replaced.  
One of the most challenging treatment goals in dentistry is the replacement of 
missing teeth. The traditional approach is to maintain the patient’s existing dentition for 
as long as possible before resorting to tooth replacement options. Some of the 
conventional tooth replacement options are complete dentures, removable partial 
dentures, and fixed partial dentures. All of these options bring with them a rigorous 
maintenance and repair regimen. It has been known for some time that when a tooth is 
lost, the surrounding bone will gradually resorb in both height and width.4 This has been 
referred to as disuse atrophy, which suggests that the body eliminates bone that is not 
actively stressed. According to Wolff’s law, bone adapts its mass and structure to the 
mechanical demands placed on it.4 These concepts raise concern for the dentist who is 
trying to maintain normal function of the dentition as well as prevent bone loss. A 
logical solution to this challenge is the use of dental implants, which will create 
mechanical stress on the bone in order to prevent bone resorption. While humans have 
attempted to replace natural teeth with implants for more than 1500 years, this did not 
become a reliable treatment option until the 1970’s.5, 6 
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Early dental implant technology consisted of blade and transosteal implants, and it 
was thought that both of these implant types relied on mechanical retention.7 A wide 
array of metals and implant designs were used unsuccessfully. One implant design that is 
frequently referenced is the subperiosteal blade implant developed by Dahl in the 
1940’s.8 This implant was inserted between the bone and the soft tissue and therefore 
relied on soft tissue anchorage. These implants were fraught with complications and 
were typically removed soon after placement due to infection, inflammation, and foreign 
body response.9 At the same time, further research was underway by Lee which involved 
implants inserted directly into the bone, referred to as endosseous implants.8 
It was later discovered that a biological phenomenon takes place where the bone 
remodels and grows around the endosseous implant. This phenomenon was first 
described by Bothe in 1940 and by Leventhal in 1951, however, it was not until 1952 
that P.I. Brånemark coined the term osseointegration.6, 10, 11 Brånemark was studying 
blood flow in rabbits and discovered that titanium chambers placed in the rabbit tibia 
and fibula could not be removed from the bone. With this knowledge, he developed a 
dental implant fixture using pure titanium screws which had predictable long-term 
results.12 This accidental discovery reinvigorated the field of implant dentistry and lead 
to the incorporation of implants into dental training programs. 
Years after the original Brånemark implants were produced, Drs. Schroeder and 
Straumann of Switzerland worked with various alloys used in orthopedic surgery in 
order to develop their own dental implant.13 In 1980, Schroeder initiated the 
International Team for Implantology (ITI) which helped stimulate advances in implant 
research and development. Several implant designs were developed and tested, including 
the Core-Vent, Stryker root form, and IMZ implants.7 After years of testing, mainly 
through trial and error, some implants left the market and others withstood the test of 
time. The most popular dental implant designs used today are threaded, root-form 
implants with various surface treatments to facilitate osseointegration. 
 The original Brånemark implants had a smooth, machined surface, while most 
modern day implants have a roughened surface. The original Brånemark implants called 
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for a six-month healing time before loading while the modern day roughened surface 
implants can be loaded in as little as six weeks.14 The roughened implant surface creates 
an increase in surface area allowing for increased bone apposition and better stress 
distribution along the implant body.15 It has been shown that a roughened surface 
promotes bone formation by increasing the proliferation of cytokines, growth factors, 
and osteoblasts.16 Some common surface treatments to create this roughened surface 
include sandblasting, acid etching, anodizing, electrochemical treatment, vacuum 
treatment, thermal treatment, and laser treatment.17 Looking at these smooth and rough 
surface implants side by side, investigators have found that soft tissue tends to adhere 
more readily to a smooth surface while bone tends to favor a roughened surface.18 This 
concept has led some implant companies to include a smooth collar at the top of their 
implant to facilitate soft tissue adherence. 
A commonly used term in dentistry is biologic width, which refers to the soft tissue 
attachment to a tooth just above the level of the bone. This soft tissue barrier includes 
three main components: sulcus, epithelial attachment, and connective tissue 
attachment.19 The biologic width serves as a seal between the bone and the outside 
world. In health, this soft tissue seal prevents bacteria and debris from causing bone loss 
around the tooth. With implants, the dentist tries to recreate this biologic width in order 
to prevent bone loss. Berglundh studied the biologic width around teeth and implants 
and found that while the epithelial attachment was similar, the connective tissue did not 
attach to the implant surface.20 Other studies emphasized that the epithelium adheres to 
the implant via hemidesmosomes, as is seen with teeth, but the connective tissue 
encircles the implant without attaching to the implant.21, 22 These results suggest that a 
tooth has a stronger biological seal than that of implants making the implant more prone 
to violation of this seal by bacteria and other debris.  
Titanium became the material of choice for implants in both the dental and medical 
fields due to its biocompatibility and ability to osseointegrate. Biocompatibility is 
defined as the ability of a material to perform with an appropriate host response in a 
specific application.23 Titanium is considered the most biocompatible metal due to its 
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resistance to corrosion from bodily fluids, inertness, and relatively high fatigue limit. A 
more real-world definition for biocompatible is an implant that is walled off in a tough, 
thin, avascular capsule that is quiescent.24 Titanium does indeed follow this real-world 
definition. 
A common misconception is that bone is in intimate contact with titanium. However, 
when a titanium implant is osseointegrated, bone is in close proximity to the implant, but 
does not adhere to it.24 There is a thin biological layer between the bone and the implant, 
approximately twenty to fifty nanometers thick, referred to as the “zone of tolerance.”25, 
26 This zone is composed of a titanium oxide layer, ground substance, and a cloud of 
zwitterionic forces that create enough friction to prevent movement of the implant. A 
zwitterion is a molecule that contains both a positive and a negative charge and therefore 
serves as a buffer between two dissimilar molecules. The titanium oxide layer is one of 
the key components that makes titanium biocompatible. The oxide layer insulates the 
titanium and serves as a buffer between the titanium and bone. Without a titanium oxide 
layer, titanium would become highly reactive and susceptible to corrosion.24 
Dental implants are regarded as a safe and highly effective treatment option for 
replacing missing teeth.24 Compared to the traditional tooth replacement options, dental 
implants have several benefits. Implants help maintain the bone level, they prevent the 
need for drilling on adjacent teeth, and they provide a fixed restoration. This allows for 
superior esthetics and function when compared to alternative tooth replacement options. 
However, many dentists have been under the false pretense that implants are the cure-all 
to restoring the patient’s dentition. This has resulted in dentists removing teeth that are in 
a less than ideal condition in order to replace them with implants. This sounds good in 
theory, but it relies heavily on the assumption that implants are a safe long-term solution.  
Due to the large number of implants being placed by a wide array of dental 
professionals, the modern dentist is faced with multiple implant complications. 
Giannobile published an article entitled “Are Dental Implants a Panacea?”27 This article 
discusses the trend in dentistry to remove teeth that could have been salvaged in order to 
replace them with a “newer, better” implant. Giannobile provides several references 
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supporting the notion that even a severely compromised tooth may have longevity that 
far surpasses that of the average dental implant.28, 29 Furthermore, Derks et al. made a 
bold argument that forty-five percent of implant patients have peri-implantitis.30 The 
authors aggressively defined peri-implantitis as an implant with bleeding on probing and 
greater than 0.5 mm of bone loss. Literature would typically categorize this scenario as a 
healthy implant.31 Nonetheless, Giannobile, Derks, and others32 have made stark 
statements about implants in order to prove a point. Dental implants should not be 
regarded as a panacea and they certainly are not immune to complications.  
Currently active implant companies have commercialized and simplified the process 
of implant placement and implant restoration. Also, there is an incredibly high profit 
margin with implants, market driven, which could result in a biased treatment plan. The 
original Brånemark implants were typically placed in a sterile operating room setting by 
oral and maxillofacial surgeons, while today, most implants are placed in a private 
practice setting by a variety of dental professionals. Countless continuing education 
courses and dental school curricula include training on the placement and restoration of 
dental implants. As a result, implants are being placed and restored by individuals with 
varying educational backgrounds. According to Adell, inexperienced surgeons had a 5-
year implant survival rate of 75 % while experienced surgeons had a 5-year survival rate 
of 98 %.33 Lambert found that inexperienced surgeons had implants fail twice as often as 
experienced surgeons.34 Da Silva conducted a practice-based research network study 
where implant parameters were measured over time in multiple general dentists’ 
offices.35 The study found that after four years, seven percent of the implants were 
classified as failures and 18.7 percent were considered to have excessive bone loss. The 
authors concluded that general dentists have a higher implant failure rate when 
compared to the failure rate of specialists. 
The pioneers of implantology have indeed paved a wonderful path with a promising 
future, but it is important to acknowledge that implants can lead to major complications 
in the oral cavity. In an effort to standardize the evaluation of implant health, 
Albrektsson et al. formulated the criteria for implant success in 1986.31 The criteria 
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include: 1) immobility of the implant; 2) a lack of peri-implant radiolucency on a 
radiograph; 3) less than 0.2 millimeters vertical bone loss after the first year of service; 
4) absence of pain, infection, neuropathy, paresthesia, or violation of the mandibular 
canal; and 5) a minimum success rate of 85 percent at five years and eighty percent at 
ten years. The authors also stated that 1.5 millimeters of crestal bone loss within the first 
year would be considered a success as this may be due to the body establishing a 
biologic width around the implant. 
Implant design has changed significantly since the Albrektsson publication in 1986. 
Most modern-day implants utilize a design known as platform switching in order to 
maintain the bone level over time. Platform switching is when an implant is restored 
using an abutment that is of narrower diameter than the implant diameter. For example, 
if the implant is six millimeters in diameter, the portion of the crown that is attached to 
the implant is four millimeters in diameter. This concept was accidentally discovered 
when 3i Implant Innovations used abutments that were narrower than their implants. 
Lazzara and Porter reported that less bone loss was seen with platform switching.36 This 
is based on the concept of osseointegration of a roughened titanium surface and the 
concept of biologic width. The platform switch allows for the bone to osseointegrate to 
the very top of the implant without a separate restorative component impinging on this 
bone to implant connection. This also will allow the body to create a biologic width 
around the abutment and crown as opposed to it occurring on the implant itself. Due to 
platform switching, in contrast with platform matching, one can expect to have less bone 
loss after implant restoration.37, 38 
According to recent studies, platform switched implants have minimal bone loss in 
the first year of service, and bone will even grow back to the coronal portion of the 
implant over time. Chrcanovic reported on Nobel implants that had been followed for 
twenty years and found that eleven percent had a gain in bone height and thirty-six 
percent had bone loss less than one millimeter.37 Froum found an average of 0.8 
millimeters of bone loss after one year, which decreased to only 0.3 millimeters of bone 
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loss at eight years.39 These results are encouraging and are clearly superior to the 
expectations proposed by Albrektsson. 
When an implant does not meet the Albrektsson criteria for success, it is typically 
diagnosed with some form of peri-implant disease. Implants with peri-implant disease 
are categorized by the American Academy of Periodontics as having either peri-implant 
mucositis or peri-implantitis.40 Peri-implant mucositis entails the inflammation of the 
soft tissue around an implant without the loss of bone.41 Peri-implantitis involves 
inflammation of the soft tissue and progressive bone loss around the implant. According 
to a systematic review by Atieh et al.,42 peri-implant mucositis affects 63% of implant 
patients while peri-implantitis affects 19% of patients. In order to aid the clinician in 
determining a prognosis of a diseased implant, Froum et al.43 have classified peri-
implantitis into three different categories: early, moderate, and advanced. Early peri-
implantitits is defined as an implant with a periodontal probing depth of greater than four 
millimeters, with bleeding upon probing and bone loss of less than 25 percent of the 
implant length. Moderate peri-implantitis entails probing depths from six to eight 
millimeters with bleeding upon probing and 25 to 50 percent bone loss. Advanced peri-
implantitis is an implant with a periodontal probing depth of greater than eight 
millimeters, with bleeding upon probing and bone loss of greater than 50 percent of the 
implant length. 
Peri-implantitis can eventually result in implant failure, which usually requires 
surgical removal of the implant in order to prevent further pain, infection, and bone loss. 
Becker et al.44 described implant failure as the presence of implant mobility and 
radiolucency around the implant. While this is a broad definition, several other clinical 
observations such as pain, infection, tissue inflammation, and degree of bone loss help 
the clinician determine whether the implant is salvageable or needs to be removed. 
Several studies have evaluated factors that could contribute to implant failure, yet in 
many cases the cause remains unknown. The timing of implant failure and an 
understanding of the healing process are useful tools that aid the clinician in determining 
the potential causes of failure. Chrcanovic et al.45 define primary, or early, implant 
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failure as an implant that fails to osseointegrate after it has been placed in bone (i.e., 
failed to form a close union between the implant and surrounding bone during healing). 
Some studies speculate that primary implant failure could be due to overheating of the 
bone and/or poor surgical technique, however, they have not shown a cause and effect 
relationship.46, 47 
Chrcanovic et al.45 state that secondary implant failure occurs later than primary 
implant failure and is due to progressive bone resorption around the implant (i.e., 
advanced peri-implantitis). Studies show that bone loss around an implant could be 
associated with one or more of the following: poor clinical handling, poor implant 
design, complex patient medical history, poor oral hygiene, overloading of the implant 
due to the crown being too high, excess cement, or a response to foreign particles 
embedded in the tissue.45, 48-51 Some of the clinical parameters for secondary implant 
failure include deep probing depths (using a periodontal probe), bleeding upon probing, 
purulence, pain upon palpation or percussion of the area, and radiographic bone loss. 
 
Risk Factors for Implant Disease 
 
The literature discusses several patient-related risk factors that must be considered 
when studying implant disease. Smoking and its relationship to periodontal destruction 
has been discussed extensively in the literature.52, 53 A longitudinal study by Miller et al. 
conducted statistical analyses of several variables that may contribute to tooth loss and 
found that smoking was the most important risk factor for tooth loss.54  
Several mechanisms by which smoking affects wound healing are discussed by 
Rivera-Hidalgo.55 Nicotine decreases the proliferation, attachment, and chemotaxis of 
periodontal fibroblasts. Fibroblasts are a key cell that function in the healing and 
turnover of periodontal tissues. Smokers also have a decrease in oxygen delivery to the 
periodontal tissues which leads to an increase in anaerobic bacteria. One of the key 
immune cells, the polymorphonuclear leukocyte (PMN), aids in preventing periodontal 
destruction. In smokers, these PMN cells have decreased motility and function. Smokers 
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typically experience severe xerostomia, or dry mouth, which allows an increase in 
bacterial adhesion to the soft tissue and inadequate salivary flushing mechanisms. The 
small capillary network in the soft tissue shows less perfusion of blood to the tissue in 
smokers. This means that the tissue is unable to receive enough nutrients and it is unable 
to rid itself of waste products. Budunelli et al. found that smokers have an altered 
RANKL to osteoprotegrin ratio.56 RANKL is an acronym for receptor activator of 
nuclear factor kappa-B ligand, which binds to RANK in order to trigger bone resorption. 
Osteoprotegrin is a protein that can bind RANKL in order to minimize its effects. 
Simplistically, this means that in smokers, the signaling molecules are allowing for bone 
destruction as opposed to bone formation. Finally, an increase in advanced glycation 
end-products (AGEs) results in a decrease in oxygen delivery to the tissues and a 
decrease in collagen turnover.57 
The literature clearly demonstrates the detrimental effects of smoking to the 
periodontium. Smoking appears to have a similar impact on dental implant health as 
well. Karbach et al. found that smoking was the most important risk factor for the 
formation of peri-implant mucositis.58 It has also been shown that bone loss around 
implants in smokers is twice that observed in nonsmokers.59 Another study that looked at 
long-term results of implants found that the rate of implant failure was higher for 
smokers than for non-smokers.60 The authors concluded that the higher failure rate in 
smokers was due to a reduced healing capacity. 
The modified implant surface may have a beneficial effect for smokers. One study 
compared machined implants and oxidized implants in smokers and nonsmokers.61 The 
authors found that with machined implants, smokers lost twice as much bone as 
nonsmokers. However, with oxidized implants, smokers and nonsmokers showed similar 
bone levels and failure rates. Balshe and coworkers found that rough surface implants in 
smokers had no significant failure rate, but the failure rate was significant for smooth 
surface implants.62 Chung et al. studied a variety of implant designs in smokers and 
nonsmokers placed over a 21-year period.63 They found that smokers had almost three 
times more annual bone loss than nonsmokers. While some studies show reassuring 
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results with rough surface implants, smoking is still considered a risk factor for peri-
implant disease. 
A large body of literature discusses the effects of diabetes mellitus on periodontal 
health.64, 65 Many of these studies state that there is a bidirectional relationship in which 
the stability of one disease influences the other. Löe was the first to suggest that 
periodontal disease is the sixth complication of diabetes.66 Some of the common 
complications found in diabetics include cardiovascular disease, neuropathy, 
nephropathy, retinopathy, and vascular changes. When a patient has prolonged elevated 
blood glucose, there is an increase in advanced glycation end-products (AGEs), which 
results in diminished oxygen delivery to tissue and poor collagen turnover. There is also 
a decrease in PMN leukocyte motility and function, decreased fibroblast function, and 
increased RANKL/osteoprotegrin ratio.65 Some of these detrimental changes are similar 
to those seen in smokers and will undoubtedly have an effect on bodily function and on 
healing capacity. A patient with well-controlled diabetes will typically have fewer of 
these sequelae and will hence heal better than an uncontrolled diabetic. 
For both periodontal therapy and implant therapy, it is believed that a well-controlled 
diabetic (Hemoglobin A1C £ 7) will fare well during the healing stages.67 Lab studies 
have shown that diabetic pigs have less bone-to-implant-contact and that rats injected 
with AGEs exhibit a slower rate of osseointegration.68, 69 Another study on diabetic rats 
found decreased bone density around the implants.70 Studies in humans have found a 
correlation between uncontrolled diabetes and bleeding upon periodontal probing around 
implants, but they did not report an increase in bone loss or implant failure among 
diabetics.71-73 
Osteoporosis is known for causing a decrease in bone density and is typically found 
in postmenopausal females.74 In general, multiple cohort and meta-analysis studies have 
found a slight correlation between osteoporosis and implant failure, but the correlation is 
weak and not statistically significant.75, 76 Many osteoporosis and cancer patients are 
prescribed bisphosphonates, which decrease bone loss by inhibiting osteoclasts. 
Osteoclasts are bone cells that degrade bone into its mineral components and osteoblasts 
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are bone cells that deposit new bone. Both of these cells are synergistically essential for 
bone turnover and bone healing. Without the help of osteoclasts, the jawbone is lacking 
in healing capacity and is therefore susceptible to a condition known as bisphosphonate-
related osteonecrosis of the jaw (BRONJ). Several other medications, such as RANK 
ligand inhibitors and antiangiogenics induce a similar phenomenon and so the term has 
been changed to medication-related osteonecrosis of the jaw (MRONJ).77  
MRONJ is typically encountered when an oral surgery procedure is done that relies 
on the healing capacity of the jawbone. Certain bisphosphonates, such as intravenous 
(IV) and nitrogen-containing oral bisphosphonates, are associated with a higher 
incidence of MRONJ.77 Shabestari et al. conducted a case series on 21 patients taking 
oral bisphosphonates and found that bisphosphonates had no effect on implant health.78 
A retrospective study on 362 patients treated with dental implants found no correlation 
between bisphosphonates and implant failure, but there was a correlation with implant 
thread exposure over time.79 The use of implants in patients taking oral bisphosphonates 
has been shown to be relatively safe, but it is ultimately up to the clinician to determine 
if the patient is a candidate for dental implant therapy. 
Radiation therapy is often administered for the treatment of head and neck cancer.74 
This treatment can result in severe dry mouth and altered function of the bone and soft 
tissue. Oftentimes, physicians will recommend hyperbaric oxygen therapy prior to 
surgical procedures in order to enhance healing capacity. Similar to MRONJ, a history of 
radiation therapy can result in a condition known as osteoradionecrosis of the jaw. A 
systematic review including 10,150 implants found that implants placed in irradiated 
bone had a 174 percent higher chance of failure.80 The authors found no correlation with 
hyperbaric oxygen therapy and improved implant success. 
A commonly discussed risk factor for implant disease is periodontal disease. 
Periodontal disease has a wide array of causes and risk factors, but is most commonly 
associated with bacterial plaque and the host immune response.81 Periodontitis and peri-
implantitis are both typically associated with a certain bacterial profile, namely, gram-
negative anaerobic bacteria.82 In addition, certain patients may be more susceptible to 
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deterioration of the periodontium due to countless variables such as medical history, 
social history, bacterial flora, and genetic profile.81 
A cross sectional study including 109 volunteers found implant failure to have a 
significant correlation with periodontitis.83 Swierkot et al. conducted a prospective long-
term study on patients with a history of generalized aggressive periodontitis, formerly 
known as juvenile periodontitis.84 Despite the fact that the aggressive periodontitis was 
controlled prior to implant placement, it was found that these patients were more 
susceptible to peri-implantitis, peri-implant mucositis, and implant failure when 
compared to healthy control patients. Another longitudinal cohort study on adults found 
a significant correlation between severe chronic periodontitis and late implant failure.85 
Costa et al. found that when patients with peri-implant mucositis did not attend regular 
maintenance appointments, they were much more likely to develop peri-implantitis.86 
These authors again found a significant correlation between periodontitis and peri-
implantitis. 
Based on these findings, the dental professional must remain abreast of current 
research with regard to risk factors for developing implant disease and implant failure. 
Smoking, diabetes mellitus, antiresorptive therapy, antiangiogenic therapy, radiation 
therapy, and periodontal disease are some of the more common risk factors discussed in 
the literature. Of these risk factors, several studies suggest that smoking and periodontal 
disease are the most prevalent risk factors for developing implant disease.82, 83, 85, 87  
 
Etiology- Bacterial Plaque 
 
One of the most controversial and highly studied questions in dentistry is “what 
causes implant disease?”41, 42 As with teeth, the cause of implant disease is typically 
regarded as multifactorial. Assuming that all risk factors are controlled and the patient is 
healthy, the patient is still prone to developing implant disease or implant failure due to a 
plethora of etiologies. 
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A commonly discussed primary etiology for gingivitis and periodontitis is bacterial 
plaque.81 This has resulted in extensive research on the role that bacterial plaque plays in 
peri-implant diseases. The formation of a well-organized biofilm on an implant has been 
shown to be capable of initiating and propagating peri-implant disease.41 The mechanism 
by which this occurs is considered to be similar to that with teeth. Peri-implant mucositis 
can develop in a similar manner as gingivitis and peri-implantitis can develop in a 
similar manner as periodontitis. The early stages involve soft tissue inflammation and a 
shift from gram-positive aerobic bacteria to gram-negative anaerobic bacteria. If this 
early lesion is left unclean and uncontrolled, the plaque matures and the inflammation 
can progress resulting in bone loss. 
In 1965, Löe was able to demonstrate in humans that the accumulation of bacterial 
plaque on teeth leads to gingivitis and that gingivitis resolves once oral hygiene is 
reinstituted.88 Pontoriero et al. conducted a similar study on implants, using teeth in the 
same patients as a comparison.40 After three weeks of plaque accumulation, the teeth and 
implants both displayed similar changes in bleeding, swelling, probing depth, and 
bacterial profile. There was no statistically significant difference between the teeth and 
implants after plaque accumulation. The teeth developed gingivitis as expected and the 
implants developed peri-implant mucositis. One criticism with this study is that the 
authors did not take measurements after the patients resumed oral hygiene and therefore 
did not demonstrate whether peri-implant mucositis is a reversible process. Salvi et al. 
conducted a similar study and included clinical measurements three weeks after 
reinstitution of oral hygiene.89 Gingivitis and peri-implant mucositis were found to be 
reversible at the biomarker level, but the clinical parameters had not yet reached the pre-
experimental levels. These parameters did however show trends toward resolution in 
both teeth and implants. 
The term peri-implantitis was first used by Mombelli in 1987 when he discovered 
that implants with bone loss harbored gram-negative anaerobic rods, black-pigmented 
bacteroides, fusobacterium species, and spirochetes.90 When evaluating the microbiota 
of healthy implants in the same patients, Mombelli saw predominantly coccoid cells. He 
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referred to peri-implantitis as a site-specific infection, which has many features in 
common with periodontitis.  
Peri-implantitis is thought to be initiated in a manner similar to periodontitis, namely 
by a mounting bacterial insult and a host response.41, 42 Some studies show a similar 
bacterial profile for both peri-implantitis and periodontitis, while others show a unique 
profile for peri-implantitis.91 An independent study group of thirty clinical experts met in 
Italy to systematically review the literature on peri-implantitis.91 They concluded that 
peri-implantitis is not comparable to periodontitis since several anatomical differences 
exist between the periodontium and the peri-implant environment. The review supported 
studies that showed peri-implantitis to have gram-negative anaerobes, opportunistic 
microbes, Epstein-Barr virus, anaerobic gram-positive rods, and Staphylococcus aureus. 
Some have suggested that S. aureus is the microbe that initiates peri-implantitis, but this 
notion was refuted by the aforementioned review in Italy.92, 93 
Periodontitis and peri-implantitis have also been shown to have a similar 
inflammatory cascade.41 They both show an upregulation of proinflammatory cytokines 
such as interleukin (IL)-1, IL-6, IL-8, IL-12, and tumor necrosis factor (TNF)-a.41 
However, one key difference is that peri-implantitis typically progresses more rapidly 
than periodontitis. Based on the studies of osseointegration and biologic width around 
implants, the protective barrier around implants is not as resilient as that found around 
teeth. Teeth have a connective tissue attachment and inserting collagen fibers along the 
root, while implants lack connective tissue attachment and simply have an avascular 
space between the implant and the bone. A recent comparison claimed that teeth have a 
self-limiting process where a protective connective tissue capsule separates the lesion 
from the bone.94 This process was not found with implants and the lesion extended into 
the bone. 
Most modern implants have undergone some sort of surface modification and 
therefore have a rough surface. This surface provides a niche for bacterial plaque to 
firmly attach to the implant and therefore create a mature bacterial colony.95 Ultrasonic 
and hand instruments can usually remove the majority of plaque from a tooth, but they 
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usually do not remove all of the hard deposits known as calculus.96 With implants, 
removal of bacterial plaque and calculus can be even more challenging simply due to the 
topography of the implant surface. This poses a challenge for the clinician once the 
bacterial plaque has reached the implant itself. Some implant companies supply “tissue-
level” implants that have a polished collar at the very coronal portion of the implant. 
This polished titanium is much easier to clean and allows for soft tissue adhesion. The 
drawbacks with this design are poor esthetics and difficulty creating a properly shaped 
crown as it emerges from the implant. 
 
Etiology- Occlusion 
 
Occlusion is another potential etiology for implant disease and implant failure. 
Occlusion has been studied extensively on teeth, but there is still a paucity of evidence 
regarding occlusion on implants.97 A tooth is suspended within its bony housing by the 
periodontal ligament (PDL). The PDL serves as a shock absorber which distributes 
forces along the root.98 The PDL also contains mechanoreceptors, which allow the 
patient to feel if they are chewing too hard on a tooth. Implants on the other hand lack a 
PDL and are simply in close proximity to the bone. Implants therefore lack the shock 
absorber effect of the PDL and do not move or give when the patient is chewing. This 
results in a concentration of forces at the crestal bone around implants.98 A tooth can 
move 25 to 100 micrometers (µm) in the vertical direction and 56 to 150 µm 
horizontally. Implants can move 3 to 5 µm vertically and 10 to 50 µm horizontally. 
Implants also produce less tactile sensation and occlusal awareness.99 The clinician is 
therefore faced with the challenge of creating a fine-tuned occlusal scheme that prevents 
excessive forces when the implants are in function. 
According to Wolff’s law, the bone adapts to the mechanical stresses placed on it.4 
Frost found that this could result in either bone deposition or bone resorption depending 
on the direction and magnitude of the forces.100 He found that a very low amount of 
strain on the bone could result in disuse atrophy of the bone. A mild amount of strain 
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allows for a “steady state” of bone damage and bone repair. However, an increased level 
of strain resulted in bone resorption and even bone fracture. 
When teeth are exposed to excessive occlusal forces, this is known as occlusal 
trauma. This may result in bony changes, occlusal wear, widened PDL, and tooth 
mobility.101 With implants, the appropriate term is occlusal overload. This occurs when 
either normal function or parafunctional habits result in structural or biological 
damage.102 Occlusal overload can result in damage to the prosthesis, implant, or 
surrounding bone. Many have suggested that peri-implantitis and occlusal overload are 
the two most common causes of late implant failure.97 
Implant studies state there is a possible relationship between occlusal overload and 
crestal bone loss, but that it depends on other factors as well.103 Kozlovsky et al. 
demonstrated in a dog model that occlusal overload with uninflamed mucosa resulted in 
a slightly reduced marginal bone level.104 However, bone loss beyond the implant neck 
only occurred when both occlusal overload and peri-implant inflammation were present. 
Some of the more common encounters seen with occlusal overload are prosthetic 
screw loosening, screw fracture, prosthesis failure, and implant fracture.105, 106 Implant 
fracture can lead to peri-implant bone loss resulting in complete implant failure.107 
In order to prevent costly implant repair and replacement procedures, an ideal 
occlusal scheme must be created to maximize implant longevity. Based on studies by 
Wolff and Frost, it makes biomechanical sense to minimize the amount of cantilever 
forces in the prosthetic design.4, 100 In other words, it is preferable to have biting forces 
that are primarily in a vertical direction as opposed to torqueing forces that are pushing 
heavily on a specific side of the implant. Cantilever forces are minimized by using an 
implant prosthesis that is slightly narrower than a normal tooth. It is preferable to have a 
prosthesis that does not extend too far in any direction beyond the diameter of the 
implant itself.97 The cusp inclination in the design of the crown can also result in non-
axial shearing forces when in function. 
Crown to implant ratio is a topic that is debated in the literature.108 Many authors 
have found equal success rates when using short versus long implants, while others have 
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found inferior results with short implants.109, 110 A common argument is that since the 
majority of the forces are at the coronal portion of the implant, then the apical portion 
must not matter. A consensus to this debate remains to be seen, but most clinicians and 
implant companies prefer implants that are at least eight millimeters in length.111 
When the patient is in maximum intercuspation (i.e., biting down), the implant 
crown should have very light or no occlusal contact with the opposing tooth.107, 112 This 
is done to compensate for the lack of PDL around the implant. When a patient goes from 
a normal bite to a heavy bite, the PDL will allow the teeth to compress, but the implant 
will remain stationary. In addition, when the patient is moving their jaw in a lateral or 
excursive direction, there should be no contact on the implant crown. 
Parafunctional habits must also be considered during implant therapy. Patients who 
brux (grind their teeth) or clench their teeth have a higher risk of implant failure.113 
These patients may benefit from wearing an occlusal night guard in order to prevent 
excessive forces from parafunctional habits. For both teeth and implants, a favorable 
occlusal scheme can have a large impact on the wear patterns that are seen after years of 
function. 
 
Etiology- Surgical Technique 
 
Another potential etiology for peri-implant disease is the clinical technique used for 
implant therapy. A great deal of demand for dental implant treatment exists among 
dental professionals and among the public as well. This has led clinicians to use implants 
in unique and innovative ways that do not follow the aforementioned biological and 
mechanical principles.  
If the implant is not placed into bone of sufficient quality and quantity, the implant 
will be at a much higher risk for failure.111, 114 Primary stability is a requirement for 
osseointegration to occur. If the implant is mobile at the time of placement, it will be at 
risk for failure. Leckholm and Zarb developed a bone classification system to aid the 
clinician in implant planning.115 Type I bone is compact cortical bone, type II is dense 
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trabecular and cortical bone, type III is dense trabecular bone with thin cortical bone, 
and type IV is low-density trabecular bone surrounded by thin cortical bone. Seibert 
created a classification system for the shape of the defect in edentulous sites.116 A class I 
defect entails a loss of defect width, class II is a loss of defect height, and class III is a 
loss of both width and height. The maxilla typically has less dense bone than the 
mandible and the posterior jaws are typically less dense than the anterior regions. As a 
result, the mandible typically has higher implant success rates and the posterior maxilla 
has higher failure rates.117 
The condition of the soft tissue is another critical variable for implant therapy. The 
biologic width around implants is less than ideal and so the quality and quantity of soft 
tissue can play a role in implant health. With teeth, a lack of keratinized tissue (gingiva) 
can result in inflammation, recession, and even tooth loss.118 With implants, the topic of 
keratinized mucosa is controversial due to a lack of sufficient evidence. Wennström 
demonstrated that health can be maintained around both implants and teeth that do not 
have keratinized mucosa.119 It must be noted that these results were obtained in patients 
with adequate homecare and periodic professional cleanings. Others have found that 
while a lack of keratinized mucosa does not affect implant survival, there is a greater 
degree of plaque accumulation and mucosal inflammation.120 Block et al. found that a 
lack of keratinized mucosa is associated with crestal bone loss of two millimeters or 
more and that keratinized mucosa is directly correlated with soft and hard tissue 
health.121 Therefore, a lack of keratinized mucosa could be an anatomical or surgical 
flaw that affects implant health. 
Surgical trauma during implant placement should be minimized in order to maximize 
the likelihood of proper healing. Bone is a living tissue, sensitive to heat, and 
overheating of bone during preparation of the site for an implant can lead to necrosis.122 
The clinician must use the proper drilling sequence and cooling mechanisms in order to 
minimize trauma to the bone. Occasionally, the surgeon will inadvertently create a 
fenestration in the bone resulting in the implant being in contact with soft tissue during 
  19 
healing.111 This situation can have a direct impact on whether or not osseointegration 
will occur. 
An aseptic surgical field will help minimize bacterial contamination and will result 
in lower implant failure rates as well.111 It is recommended that the surgeon use sterile 
instruments, proper draping, and careful handling of the implant after removal from its 
package. 
A popular surgical technique is the flapless approach to implant placement. This 
technique typically entails creating a small hole in the soft tissue and then preparing the 
implant bed through this hole. The benefits to this approach are less post-operative pain 
and less trauma to bone and soft tissue.111 Many believe that this will result in better 
healing and esthetics. Froum et al. conducted a study comparing flapless and flap 
protocols for implant placement.39 After eight years, they found no difference in bone 
levels, probing depths, bleeding on probing, or papilla height. The authors concluded 
that both protocols were successful. With advances in radiology and three-dimensional 
implant planning, it is feasible to use the flapless protocol as long as proper surgical 
technique is exercised. 
Implants can be placed using a one-stage or a two-stage protocol. The one-stage 
protocol entails placing an implant and a transmucosal healing abutment at the same 
time. This allows the implant to osseointegrate and it allows the tissue to heal around the 
abutment. With the two-stage protocol, the implant is buried underneath soft tissue and 
later uncovered for attachment of a healing abutment. The benefits to the one-stage 
protocol are reduced time, money, and surgical trauma.111 The healing abutment also 
allows for the early formation of a biologic width while the implant is healing. The 
drawbacks to the one-stage protocol are the potential for bacterial contamination of the 
implant during healing and the potential for trauma to the implant by the patient. With 
the two-stage protocol, the implant is allowed to completely integrate prior to its 
exposure to the bacterial flora and mechanical forces of the oral cavity. Several studies 
show a decreased risk of implant failure using the two-stage protocol, but the clinician 
must decide whether it is worth the additional time, money, and surgical trauma.123, 124 
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Another surgical technique that is commonly used involves placing the implant into 
a fresh extraction socket, referred to as an immediate implant.111 This treatment can be 
beneficial to the patient since it entails one less surgery and the patient can have the 
tooth replaced by an implant sooner than conventional therapy. The drawbacks to this 
procedure are increased risk of infection, low bone to implant contact, more bone 
resorption and higher risk of implant failure.125 The tooth extraction procedure causes 
trauma to the bone and surrounding soft tissue, and implant placement on the same day 
will further traumatize this bone. This is why studies have shown an increase in bone 
resorption and failure rate with immediate implant placement versus delayed implant 
placement.126 A benefit to immediate implants that is worth noting is the ability to create 
a temporary crown or custom healing abutment on the implant. This will help preserve 
the soft tissue dimensions that were present around the tooth prior to extraction. 
Nonetheless, immediate implant placement is a potential etiology for implant failure. 
Some teeth that require removal present with a lesion around the apex of the root, 
known as a periapical lesion. Many dentists have successfully placed immediate 
implants in sockets where periapical lesions exist. The goal is to thoroughly debride and 
clean the lesion prior to implant placement. Randomized controlled trials have shown 
similar failure rates when implants were placed immediately in sockets with periapical 
lesions.127, 128 However, there is a high likelihood of not obtaining primary stability, 
which is critical for osseointegration. Interestingly, a periapical lesion on a tooth 
adjacent to the implant creates a higher risk for infection around the apex of the 
implant.129 Without proper site preparation, placing an implant into a site of active 
infection will pose a risk for implant infection and failure. 
 
Etiology- Cement 
 
The prosthetic components that attach to an implant are typically made up of an 
abutment, which screws directly onto the implant, and a crown or bridge prosthesis. The 
prosthesis can either be cemented onto the abutment in the clinic or the prosthesis and 
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abutment can be fabricated as one piece in the lab. This one-piece prosthesis is referred 
to as screw-retained since it can be screwed directly into the implant itself without the 
need for dental cement. Both cement and screw-retained prostheses are used routinely in 
the dental office, but some dentists prefer the cement-retained approach since it is 
typically more affordable. Also, the screw-retained prosthesis has a hole in the final 
crown for access to the screw. The location of the screw access hole relies heavily on 
proper implant placement so that the hole does not affect the cosmetics or function of the 
restoration. 
The drawbacks to a cement-retained prosthesis are that the crown is difficult to 
remove once it has been cemented into place and there is a potential for excess cement to 
extrude into the surrounding tissue as the prosthesis is seated. This excess cement is very 
difficult to remove and can be inadvertently left embedded in the soft tissue. In 1999, 
Pauletto et al. reported on four cases where excess cement was associated with 
inflammatory lesions around the implants.130 Deep probing depths, bone loss, and 
purulence were noted during surgical removal of the excess cement, and the lesions 
resolved after cement removal. Another case report demonstrated implant failure that 
occurred one month after crown cementation.131 During surgical removal of the failed 
implant, significant bone loss was found adjacent to an area with excess cement and 
inflamed granulation tissue. Wilson conducted a case-control study where he compared 
42 test implants with peri-implantitis to twenty healthy control implants.48 He used a 
dental endoscope to explore the condition of the peri-implant mucosa. Excess cement 
was found in none of the controls and in 34 of the test sites. Thirty days after removal of 
excess cement, 25 of 33 test sites had no clinical signs of inflammation. The author 
concluded that excess cement was associated with peri-implant disease. 
Burbano et al. studied nineteen human biopsies that were taken from implants with 
peri-implantitis and cement-retained crowns.51 The biopsies were analyzed using 
scanning electron microscopy and elemental analysis in order to determine the presence 
of dental cement embedded in the soft tissue. All nineteen of the specimens displayed 
the presence of cement, which were correlated with five different commercially 
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available cements. Penarrocha-Oltra et al. studied the presence of different bacteria 
present around screw-retained and cement-retained implants.132 After sampling 55 
cement-retained implants and 46 screw-retained implants, the authors found a 
significantly higher bacterial load in the cement-retained group. 
An in vitro study by Rodriguez et al. studied the effects that different dental cements 
have on human gingival fibroblasts (soft tissue forming cells) and on preosteoblasts 
(bone forming cells).133 The various dental cements had only a minor effect on the 
preosteoblasts, but they had a significant effect on the fibroblasts. There was a 
statistically significant decrease in the number of human gingival fibroblasts when 
exposed to all cements except for one. The one cement that had less of an effect on 
fibroblasts contained zinc oxide noneugenol, with the trade name “Temp-Bond.” Three 
different controlled clinical studies found no correlation between cement-retained 
crowns and implant failure.134-136 However, cement remnants are associated with soft 
tissue inflammation, increase in bacterial load, and bone loss around the implant. Excess 
cement may have an effect on implant health, but not necessarily on implant failure. 
 
Etiology- Titanium Allergy 
 
Titanium is regarded as extremely inert and biocompatible, and many are unaware of 
the possibility for an allergic reaction to titanium. There is a body of evidence, albeit 
limited, that reports on allergic reactions to titanium.137 The most common allergic 
reactions to titanium include types I, III, and IV. With type I hypersensitivity reactions, 
the patient has been previously exposed to the allergen (i.e., titanium) and will mount a 
specific immune response to the allergen using IgE antibodies. This is the classic allergic 
reaction and it typically occurs in a short period of time. Type III hypersensitivity 
reactions occur when there is an excess of antigen-antibody complexes and the body is 
unable to clear them from the affected area. This type of reaction can take days or weeks 
to develop. Type IV hypersensitivity reactions are different in that they are cell-mediated 
and not antibody-mediated. This reaction occurs when T helper cells recognize the 
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allergen and secrete cytokines that cause a chain of events to occur. Eventually, the 
environment is filled with various destructive cells such as macrophages, T lymphocytes, 
and mast cells that can cause damage to the surrounding area. Type IV reactions are 
delayed and take several days to develop.  
With orthopedic implants, several studies have reported an allergic reaction that 
caused the titanium implant to fail.137 One study reported on patients that became 
symptomatic after placement of titanium plates for fixation of bone fractures.138 
Microscopic analysis revealed the presence of T lymphocytes and macrophages 
indicative of a type IV reaction. The tissue adjacent to the titanium appeared discolored 
and further analysis revealed titanium embedded in the tissue. Another study reported on 
tissue samples from patients that had failing prosthetic hips.139 T cells and macrophages 
were again present in the tissue indicative of a type IV allergic reaction. Interestingly, all 
five of these patients revealed a negative result to a skin patch test using titanium. 
However, a titanium ointment test yielded positive results in two of these patients. 
In the dental literature, a variety of allergic reactions to titanium have been reported. 
A cohort study in Spain evaluated 1500 implant patients for potential titanium 
allergies.140 Thirty-five of these patients were suspected of having a titanium allergy 
based on a history of multiple allergies and a clinical appearance of an allergic reaction. 
Sixteen of these patients displayed allergic symptoms after implant placement or 
unexplained implant failure. Nine of these patients displayed positive reactions to 
titanium allergy tests. Based on these findings the authors gave an estimated prevalence 
of titanium allergy of 0.6 percent. 
Some implant systems utilize a titanium nitride-coated implant abutment.141 One 
case report discussed an allergic reaction to this coating, which resolved after removal of 
the titanium nitride abutment. Another article reported on a 41-year-old woman who 
experienced exfoliative cheilitis (exfoliation of the lips) after implant placement.142 A 
third case reported on a patient that experienced facial eczema after placement of two 
mandibular implants.143 The eczema resolved after removal of these implants. Titanium 
oxide is used as an additive in dermatological products, toothpaste, icing, salad dressing, 
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chewing gum, candy, milk, tattoo ink, and paints with the general consensus that it is 
safe.144 Based on this limited evidence, one can surmise that titanium allergies do occur, 
but are rare. 
 
Etiology-Foreign Body Reaction 
 
A titanium implant is considered a well-tolerated foreign body, but is a foreign body 
nonetheless. The roughened surface, the titanium oxide layer, and the “zone of 
tolerance” between the bone and the implant allow for equilibrium to exist between the 
implant and the human body.145 In some cases this equilibrium is shifted from normal 
osseointegration to a foreign body reaction. Nowzari et al. compared the levels of 
periodontal pathogens and pro-inflammatory cytokines around healthy teeth and healthy 
implants.146 The authors found more periodontal pathogens around healthy teeth yet they 
found approximately twice as many pro-inflammatory cytokines around healthy 
implants. The prominent cytokines around implants were IL-1ß, IL-6, IL-8, and TNF-a. 
For both teeth and implants, the cytokine levels were higher when bacteria were 
detected.  
With failing dental implants, it is difficult to prove if a foreign body reaction occurs 
since bacterial plaque is present as well. Orthopedic implants however are placed in a 
sterile field and are isolated from the outside world. These implants do occasionally lose 
osseointegration without an explanation other than a “foreign body reaction.”147 
Albrektsson et al. claim that initial marginal bone loss around implants is a reaction to 
treatment and not a disease process.148 They state that the initial foreign body response 
can be sustained and aggravated leading to significant bone loss and implant failure. In 
these cases, once severe bone loss has occurred, a secondary bacterial infection may 
follow. The authors state that marginal bone loss around an implant should not be 
regarded as a periodontitis-like disease, but instead a “dis-balance” of a foreign body 
response. 
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Etiology-Titanium particles 
 
A foreign body reaction to the entire implant can occur, but other evidence suggests 
that small titanium particles around the implant can provoke an immune response as 
well. It has been proven that titanium ions can be found in the tissues surrounding both 
dental and orthopedic implants, which can result in tissue discoloration and foreign body 
reactions to these particles.137, 149 The blood vessels in the nearby soft tissue and bone 
could allow these titanium particles to enter the blood stream and migrate to distant body 
organs. One study found that when dental implants were inserted into the mandibles of 
sheep, there was a slight increase in titanium found within the lungs and regional lymph 
nodes.150 Two of these implants failed resulting in a much higher level of titanium in the 
lungs and lymph nodes (7-9.4 times the levels in controls). In the orthopedic literature, 
countless articles have discussed the issue of metal debris traveling to distant organs, 
often referred to as “metallosis.”147, 151 A study on human cadavers with joint 
replacements found that 68 percent of the patients had metallic wear particles in their 
lymph nodes near the aorta.152 An additional 38 percent had metallic particles in their 
liver and/or spleen. These particles were found in aggregates surrounded by 
macrophages, which are cells that attempt to rid the body of debris. These particles were 
again more prevalent in patients that had a failed implant, which is similar to the 
findings in the sheep mandible study. 
Titanium particles can be released from the implant surface in numerous ways. 
Titanium can simply dissipate from the implant surface during and after placement, it 
can flake off of the implant due to mechanical forces, and it can exfoliate due to 
oxidative corrosion of the implant surface. These titanium particles can vary in size from 
small ions to large titanium pieces.152 
Whether titanium can exfoliate from the implant during surgical placement is a 
debatable topic. Most modern-day implants have a surface that is treated and roughened, 
which could facilitate the exfoliation of small pieces of titanium. Senna et al. inserted 
three different implant designs (Nobel, Straumann, and Astra) into bovine ribs in order 
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to evaluate the presence of loose titanium particles.153 It was found that all three implant 
designs had a decrease in both surface area and surface roughness after insertion into 
bone. Loose titanium and aluminum particles were observed, mainly at the crestal 
portion of the bone. A separate study on the titanium plasma sprayed (TPS) implant 
surface found titanium granules in the soft tissue and bone after implant insertion.154 
Suarez et al. studied five different implant surfaces and found that the grit blasted 
surface resulted in the most titanium exfoliation during placement into bovine ribs.155 
Sridhar et al. simulated surgical placement of Straumann dental implants into foam 
blocks of varying densities designed to match different bone densities seen in the 
mouth.50 The authors found that implant insertion does not result in exfoliation of 
titanium particles into the surrounding osteotomy site.  
It is sometimes difficult to determine whether these titanium particles are exfoliated 
during or after implant placement. Studies have found titanium particles in the 
surrounding soft tissue after the implant has been in function. Olmedo et al. conducted 
exfoliative cytology of the peri-implant mucosa and found metal particles embedded in 
the soft tissue of both healthy and diseased implants.156 The diseased implants displayed 
a higher concentration of metal within the soft tissue. Another study in Washington 
observed the plaque around healthy and diseased implants.157 All implants displayed 
titanium particles within the plaque, but the diseased implants had significantly more 
titanium per unit area of plaque. These titanium particles could be from implant 
placement, metal fatigue, or simply dissolution of the titanium surface over time. 
A phenomenon known as fretting corrosion occurs at the interface of two closely 
fitting surfaces when they are subjected to repeated micro-motion or vibration.151 In the 
dental field, fretting corrosion can occur between the implant and the abutment that is 
attached to it.158 Modern implant designs have attempted to minimize this micro-motion, 
but it is impossible to eliminate completely.159 A very small gap between the implant and 
abutment, known as the microgap, allows for metal fatigue over time. 
Fretting corrosion results in surface irregularities on both the implant and abutment 
and exfoliation of metal into the surrounding tissue. When metal-on-metal wear occurs, 
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the titanium oxide layer on the implant can be mechanically destroyed.151 The implant 
will now be at risk for true oxidative corrosion so it is important for the implant to 
reform a titanium oxide layer. Tawse-Smith et al. took exfoliative cytology samples 
from the tissue of implants restored with zirconia abutments and crowns.160 Elemental 
analysis revealed that high numbers of titanium particles were present at the implant 
abutment interface and in the soft tissue adjacent to the crown. Others found that when 
nonprecious metals are used for the abutment, the implant is at risk for a galvanic 
reaction between dissimilar metals resulting in corrosion and a loss of the titanium oxide 
layer.161 
The original Brånemark implants were made of commercially pure titanium, while 
the modern implant is alloyed with other metals. Iron is added for corrosion resistance, 
aluminum is added for increased strength, and vanadium acts as an aluminum scavenger 
to prevent corrosion.162 Steineman has shown that titanium alloys (TiAlV) are not as 
well integrated as pure titanium and have an enhanced corrosion rate.145 According to 
Khan, titanium alloys have a better combination of corrosion and wear resistance, while 
pure titanium shows better corrosion resistance but inferior wear characteristics.163 
Modern titanium alloys are touted to be highly resistant to corrosion, but stress and wear 
can accelerate the corrosion rate of titanium.24 
Continual loading, micro-motion, and acidic environments can result in permanent 
loss of the titanium oxide (TiO2) film and eventual corrosion.158 Oxidative corrosion 
involves losing metal due to a chemical reaction that takes place with an electrolyte or 
acid as the metal repassivates or reforms an oxide layer.151 Tribocorrosion refers to the 
combination of both fretting corrosion and oxidative corrosion. With metals in general, 
this phenomenon can occur along the entire surface or only in select locations. Typically, 
the majority of the titanium implant is stable and only a select area that lost its TiO2 
layer will experience corrosion. This phenomenon is referred to as pitting corrosion 
since it forms small pits in the areas that experience corrosion. Olmedo et al. installed 
both sterile titanium implants and implants with pitting corrosion into rat tibiae.164 The 
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implants with pitting corrosion displayed decreased bone-implant contact, and corrosion 
products were found within the bone. 
The oral environment is completely different from the sterile environment where 
orthopedic implants are placed. Dental implants are constantly exposed to a variety of 
insults every day. If the implant is exposed to an acidic environment and if micro-motion 
is present, the implant is now susceptible to corrosion. The two known modalities in 
which an implant can be exposed to an acidic environment include acidic byproducts of 
oral bacteria and decontamination medicaments used by the dentist or patient.165, 166 
It has been known for some time that normal metabolism of oral bacteria results in a 
release of lactic acid as a waste product. This can result in dental caries, gingivitis, 
periodontitis, or in this case, peri-implantitis. Sridhar et al. immersed sterile dental 
implants into either a bacterial medium or a control medium in vitro.166 The bacteria 
created a sustained acidic environment leading to discoloration, deformation, corrosion, 
pitting, and rusting of the implant surface. In a follow-up study by the same authors, it 
was found that normal mechanical forces on the implant in combination with a bacterial 
medium resulted in accelerated corrosion and dissolution of metal ions.159 These results 
were corroborated by a University of Washington study that found elevated levels of 
titanium within the plaque around implants with peri-implantitis when compared to the 
plaque around healthy implants.157 An in vitro study in Italy exposed implants to healthy 
human saliva for incremental lengths of time.167 Significant dissolution of metallic 
particles was seen as early as one week. Interestingly, trace amounts of vanadium were 
found at one day, which questions the stability of the TiAlV alloy used in modern 
implants. 
Another potential mechanism for corrosion is acidic medicaments used to 
decontaminate the implant surface. Wheelis et al. conducted an in vitro study to evaluate 
the corrosive effects of several detoxification solutions on Ti and TiAlV dental 
implants.165 The solutions included citric acid, hydrogen peroxide, chlorhexidine 
gluconate, tetracycline, doxycycline, sodium fluoride, peroxyacetic acid, and treatment 
with a CO2 laser. The treatments consisted of either immersing the implant in the 
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solution or rubbing the implant with a cotton swab soaked in solution. Implants that were 
immersed in a solution with a pH less than three displayed corrosion and pitting of the 
implant surface. The authors also noted a change in color of the acidic solutions, which 
suggests that titanium exfoliated from the implant. When rubbing was used, any solution 
with a pH less than 5.5 caused significant discoloration and pitting. Evaluation of the 
cotton swabs after they were used displayed remnants of titanium. With the immersion 
protocol, commercially pure Ti displayed less corrosion compared to the TiAlV alloy. 
These results suggest that when decontaminating an implant surface, the safest 
treatments include sodium fluoride, three percent hydrogen peroxide, and treatment with 
a CO2 laser. Chlorhexidine can be applied to the implant surface, but if it is burnished 
with a cotton swab, corrosion is possible. 
There is evidence that implant surface delamination can occur as well. 
Delamination refers to exfoliation or cleavage of a portion of the implant surface 
resulting in a large titanium particle in the vicinity and exposure of the underlying 
implant body. Rodrigues et al. have found corrosion in conjunction with surface 
delamination in both orthopedic and dental implants.158, 168 Delamination of dental 
implants can be caused by micro-motion in an acidic environment resulting in exposure 
of the inner titanium body and accelerated dissolution.158 After implant surface 
delamination, the underlying titanium body is unable to form a titanium oxide layer if it 
is not exposed to oxygen. This results in a highly reactive surface that will interact with 
nearby acids and electrolytes in order to stabilize. Sridhar et al. found that cyclic 
occlusal forces may result in surface delamination as well, which corresponds with the 
concepts of micro-motion and fretting corrosion.159 
Based on the present data, there are several avenues that can lead to corrosion of 
titanium dental implants. To the best of the author’s knowledge, there is insufficient 
evidence to say whether a corroded implant surface can be maintained in health. 
However, there is emerging evidence that suggests foreign particles embedded in the 
tissue can provoke an inflammatory response. A study on orthopedic implants 
demonstrated that metal debris can trigger inflammation in vivo.169 Wilson et al. 
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obtained soft tissue biopsies around dental implants with peri-implantitis and evaluated 
them with light microscopy and SEM.49 Titanium and/or dental cement were found in 34 
of 36 biopsies and were surrounded by plasma cells, giant cells, and other inflammatory 
cells. Another study demonstrated that titanium debris can trigger a DNA damage 
response in oral epithelial cells.155 These studies suggest that foreign debris around 
titanium implants is not well tolerated. 
The aims of the present investigation are: (1) to evaluate the presence of foreign 
particles found in proximity to failing dental implants that have been removed; (2) to 
examine the effect that these foreign particles have on the surrounding tissues. Light 
microscopy, SEM (scanning electron microscopy), and EDS (energy-dispersive x-ray 
spectroscopy) methods will be employed. 
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2. MATERIALS AND METHODS 
 
Patient Enrollment 
 
The Institutional Review Board of Texas A&M University College of Dentistry 
(TAMUCOD), Dallas, Texas, reviewed and approved the protocol for this prospective, 
cross-sectional ex vivo study. A total of 21 patients (8 males, 13 females, aged 26 to 78 
years; mean age: 61.4) possessing 34 dental implants were enrolled between May 2016 
and November 2017. One female patient never returned for implant removal resulting in 
a total of 20 patients and 33 extracted implants. Additionally, one new implant 
(NobelReplace 4.3x11.5 mm CC RP) was taken directly out of the factory packaging and 
served as a negative control. Medical history, smoking status, gender, age, and location 
of implant were recorded for each patient. Patients were enrolled when the treating 
clinician deemed the implant as either failing or non-restorable. Early failures were 
defined as implants that failed before or at time of abutment connection.170 Late failures 
were defined as implants with bleeding upon probing and/or suppuration upon probing 
with at least 50 % radiographic bone loss, which is a variation of previous definitions.43, 
44 Positive controls were defined as implants that met the criteria for implant success 
proposed by Albrektsson et al.31 These criteria include immobility of the implant; lack of 
peri-implant radiolucency; < 0.2 mm vertical bone loss after the first year of service; and 
absence of pain, infection, neuropathy, paresthesia, or violation of the mandibular canal. 
These were obtained when the implant was either non-restorable or in a location that 
may affect patient health. Participants were recruited using the convenience sampling 
method in order to maximize the sample size. Patients were excluded if they had any 
condition that contraindicated surgery, including poorly controlled systemic conditions, 
immunosuppressive medications, and pregnancy. 
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Clinical Protocol 
 
Four implants were removed in a private practice setting by Dr. Tom Wilson. All 
other implants were removed by residents with faculty supervision in the Departments of 
Graduate Periodontics and Graduate Oral and Maxillofacial Surgery. Standard surgical 
protocol was used to remove the implants, including reverse torque devices, trephine 
burs, and surgical burs as needed. The remaining sockets were debrided of any 
inflammatory tissue and augmented with a bone graft when indicated. Appropriate 
antibiotics were prescribed as needed and the patient was given the option to replace the 
implant when feasible. The extracted implant and any discarded tissues were 
immediately placed into 37 % neutral buffered formalin or type II collagenase/dispase 
enzymatic medium. 
 
Group Allocation and Laboratory Analysis 
 
 A total of 34 implants (28 failed, 5 positive control, and 1 negative control) were 
examined. Six implants (5 failed and 1 positive control) were assigned to group E, which 
was an exploratory investigation using enzymatic degradation of the peri-implant tissues. 
All remaining implants were allocated into group GS (23 failed, 4 positive controls, and 
1 negative control), which entailed histologic, SEM and EDS analysis of ultrathin 
ground sections. 
 Group E was designed for direct identification of any foreign particles embedded 
in the peri-implant tissues. These specimens were placed into type II collagenase/dispase 
and incubated at 37 degrees Celsius for 24 hours in order to enzymatically digest the 
tissues surrounding the implant. The implant was removed and the remaining medium 
was centrifuged at 2200 rpm for 15 minutes. The supernatant containing 
collagenase/dispase was removed using a pipette and the remaining 500 µL sample was 
smeared onto a glass slide and allowed to air-dry. This slide was then sputter-coated with 
gold for thirty seconds and imaged using a Jeol JSM-
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microscope. The observation conditions were metals, conductive, and the EDS detector 
was on. The map EDS function was used for elemental analysis throughout the slide. 
Any radiopaque areas were further analyzed with point EDS. The map function gives a 
general overview of the elements present throughout the specimen while point EDS 
gives the specific elements found for each point that is selected on the specimen. 
 Group GS underwent ground section preparation prior to imaging. These 
specimens were dehydrated using a series of ethanol baths (50 %, 70 %, 95 %, 100 %, 
and 50/50 mix of 100 % ethanol and 30 % Technovit), embedded in 100 % Technovit 
7200 glycol methacrylate, and sectioned longitudinally into three or four sections using 
an Exakt diamond band saw. An Exakt grinding machine was used to grind these 
sections to a thickness of approximately 100 µm. All sections were photographed using a 
Leica light microscope prior to further analysis. 
Representative histologic sections were stained using 1 % toluidine blue, rinsed 
with 70 % ethanol, and mounted using xylene-based mounting medium. They were then 
imaged using light and bright-field microscopy at 3x, 10x, 20x, 40x, and 100x 
magnification. The remaining sections were sputter-coated in gold for one minute and 
then examined and imaged using SEM at 30x, 180x, 750x, 1200x, 2200x, 3300x, and 
5500x. Any areas that displayed foreign debris or bacteria were further analyzed using 
point EDS. Several areas that appeared to have normal bone to implant contact were also 
imaged and evaluated with EDS for comparison. 
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3. RESULTS 
 
Group E 
 
 A total of 6 implants (5 failed and 1 positive control) were available for 
enzymatic digestion of the peri-implant hard and soft tissues. A representative sample 
with elemental analysis is displayed in Figure 1. All samples contained carbon, oxygen, 
and nitrogen, the primary elements in organic matter. Calcium and phosphorus were 
found in trace amounts (mean mass % of 4.9 and 1.9, respectively). Sodium and chloride 
were found in small amounts (9.28 % and 8.30 %, respectively). Silicon ranged from 0 
% to 16.8 % (mean: 7.9 %) and zinc ranged from 0 % to 12.2 % (mean: 4.3 %). Zinc was 
not found in any of the control samples and titanium was not found in any of the failed 
or control samples. 
 
Group GS 
 
 A total of 28 implants (23 failed, 4 positive controls, and 1 negative control) 
were evaluated using light microscopy and SEM. Figure 2 displays unstained light 
microscopy slides with titanium particles in the vicinity of all failing and positive control 
specimens. Compared to controls, the failed implants displayed a greater number and 
size of titanium particles (>10 µm in any dimension). These particles had a black color 
that matched the color of the titanium implant itself. In some failing implants, the shape 
of the implant surface was altered in the same area that this titanium exfoliation 
occurred. Larger particles could occasionally be matched to the implant surface from 
which it exfoliated. The positive controls displayed small and scarce (<10 particles at 
100x magnification) foreign particles with no apparent alteration to the implant surface. 
The negative control (factory implant) revealed scarce, small artifacts that were far from 
the implant surface and did not match the color of titanium.  
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 Stained slides, in Figure 3, revealed better contrast between the titanium particles 
and the surrounding tissues. Titanium particles were commonly observed in proximity to 
soft tissue, connective tissue, and bone undergoing osteolysis. Inflammatory cells such 
as PMNs and lymphocytes were observed. Titanium particles were less frequently seen 
in the vicinity of bone that appeared healthy. The positive control specimens displayed a 
smaller number of titanium particles and a greater presence of healthy bone surrounding 
the implant surface. However, titanium particles were found near the lumen of intrabony 
blood vessels for both failed and control implants. 
Delamination of the implant surface was observed in failed implants (Figure 4). 
Surface delamination was associated with the presence of inflammatory cells and 
numerous titanium particles. None of the control specimens displayed this phenomenon. 
Bacterial cocci and bacilli were seen in the vicinity of failed implant specimens, 
portrayed in Figure 5. These colonies were always associated with titanium particles. 
Bacterial colonies were not found in any of the control specimens. 
 SEM analysis of group GS revealed countless particles that could be verified as 
titanium using EDS. These particles were found in the vicinity of the external implant 
surface as well as in the screw access hole (Figure 6). 490 individual points (415 failed, 
30 positive control, 45 negative control) were selected and evaluated using EDS. Points 
that were not connected with the implant body were further evaluated. 252 points near 
failed implants and 8 points near positive control implants contained titanium. The 
titanium points had a mass percent range from 1.26 % to 100 % (mean: 38.18 %). 
Titanium points found near positive controls were within the bone-implant interface and 
were not visibly seen. The negative control implant displayed occasional debris in the 
vicinity. EDS analysis revealed that none of this debris was made up of titanium and was 
simply artifact. Figure 7 displays a fractured implant that had bacterial cocci growing 
into and around the fracture. Point EDS reveals the presence of titanium within these 
bacterial colonies.  
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4.  DISCUSSION AND CONCLUSIONS 
 
Group E entailed a laboratory method that, to the author’s knowledge, has never 
been used on peri-implant tissues. The lack of titanium particles found within these 
specimens may be due to methodical error since titanium particles were found in all 
specimens of group GS. The very small sample size in group E may have also influenced 
these results. Calcium and phosphorus, detected by EDS, were related to the presence of 
bone minerals. Sodium and chloride were most likely present due to the use of saline 
during implant removal and processing. Since glass slides contain silicon, any detection 
of silicon was considered part of the glass slide and not dental cement. However, zinc 
was present in select specimens and is not a component of glass slides. This suggests 
that the detection of zinc may be due to the presence of dental cement within the 
samples. 
 Burbano et al. conducted SEM of soft tissue biopsies taken from implants with 
cement-retained crowns and peri-implantitis.51 The elements found in five different 
commercially available cements were identifiable in all 19 specimens. These elements 
were silicon, aluminum, zirconium, and zinc. Zinc is present in cements containing zinc 
oxide eugenol (TempoCem), zinc phosphate (Fleck’s), and zinc oxide noneugenol 
(Temp-Bond). Wilson found cement in 34 of 42 peri-implantitis biopsies.48 The majority 
of these implants were restored to health after removal of excess cement. Since zinc was 
found in certain group E specimens, it is plausible that this was due to the presence of 
cement.  
All failed and positive control implants in group GS had titanium particles 
present in the vicinity to varying extents. A greater number of titanium particles were 
present near failed implants than controls, which may be due to corrosion-induced 
titanium exfoliation which has been suggested in previous studies.49, 157, 158 Some authors 
found that titanium exfoliates during implant placement and others found that it does 
not.50, 153, 155 It is possible that the present specimens experienced titanium exfoliation 
during placement and/or removal. However, this does not account for the fact that a 
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much greater number and size of titanium particles were associated with failed implants 
when compared to positive controls. Another possible dispute is that the process of 
grinding these specimens resulted in titanium exfoliation. The fact that there was no 
titanium exfoliated from the negative control (factory implant), which underwent the 
same grinding process, supports the argument that titanium is not exfoliated during 
processing. 
Titanium particles were present within the lumen of regional blood vessels in 
both failed and positive control implants, which may be cause for concern. Studies in 
both dental and orthopedic literature have found titanium particles in the lungs, regional 
lymph nodes, liver, and spleen.150, 152 These studies found higher quantities of titanium in 
distant organs for those with failing implants. The only logical means for titanium to 
travel to distant organs is through the circulatory system. The present results suggest that 
a pathway exists for titanium particles to enter the circulatory system, and it is possible 
that a greater number of particles enter circulation when the implant is diseased. 
The surface delamination found on failed implants corroborates the findings of 
several previous studies. Rodrigues et al. found corrosion in conjunction with surface 
delamination in failing orthopedic implants.168 A separate study by Rodrigues et al. 
found that delamination of dental implants can be caused by micro-motion in an acidic 
environment resulting in exposure of the inner titanium body and accelerated 
dissolution.158 The underlying titanium has not been exposed to oxygen and therefore 
never forms a titanium oxide layer. This results in a highly reactive surface that will 
react with nearby electrolytes. An in vitro study by Sridhar et al. found that cyclic 
occlusal forces result in surface delamination as well.159 The results of the present study 
show that surface delamination is observed in an unhealthy environment and is 
associated with a large number of titanium particles. 
Countless references validate that bacterial plaque is associated with peri-
implantitis and implant failure.41, 90, 91 The microbiota typically associated with peri-
implantitis are similar to those seen with periodontitis, namely, gram negative anaerobic 
rods, fusobacteria, and spirochetes.90 Interestingly, cocci were seen in one fractured 
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implant under SEM, which is a bacterium typically associated with health. A gram stain 
may have aided in identifying the bacterial characteristics. Regardless, the fact that these 
cocci were found in the body of the implant, as opposed to a healthy peri-implant sulcus, 
clearly demonstrates the lack of health for this particular specimen. 
All bacterial colonies found in this study were associated with titanium particles. 
This validates a study by Safioti et al. which found higher levels of titanium in plaque 
samples taken from implants with peri-implantitis when compared to healthy controls.157 
Another study found that bacterially produced lactic acid results in corrosion and release 
of metal particles from the implant surface.166 There is mounting evidence that bacteria 
affects not only the peri-implant tissues, but the actual implant body as well. This could 
result in an environment that is very difficult if not impossible to repair by contemporary 
peri-implantitis treatment modalities. 
 
Conclusions 
 
A greater number and size of titanium particles were found in the vicinity of 
failed implants when compared to healthy controls. These titanium particles were 
associated with bacterial plaque, delamination of the implant surface, and local 
vasculature. It is difficult to discern whether titanium particles are an initiating factor to 
implant failure or simply a result of other known etiologies. The findings in the present 
study suggest that corrosion of a titanium implant surface occurs in vivo. The resultant 
implant surface distortion and titanium exfoliation may produce an environment that is 
not compatible with health. 
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APPENDIX 
FIGURES 
 
 
Figure 1. Representative specimen from Group E. A) Image taken with SEM at 22x 
magnification. B) EDS analysis portraying the presence of Zinc and Silicon. 
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Figure 2. Unstained light microscopy depicting titanium particles in the vicinity of 
failed implants. A) Failed implant at 10X magnification with titanium debris. B) Positive 
control (healthy) implant at 20X. C) A failed implant at 20X with titanium debris. D) 
Negative control (factory) implant at 20x. 
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Figure 3. Stained light microscopy for histologic interpretation. A) Failed implant at 10x 
magnification with demineralized bone, connective tissue, and inflammatory cells. B) 
Positive control (healthy) implant at 20X. C) The same failed implant at 100X 
portraying the multitude of small titanium particles. D)The same control implant at 100X 
portraying the presence of small titanium particles in the vicinity of an arteriole. 
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Figure 4. Delamination of the failed implant surface. A) Failed implant at 40X 
magnification showing complete delamination of the external implant surface. B) SEM 
of failed implant at 1200X with inflamed soft tissue and titanium particles. EDS of the 
soft tissue lining revealed the presence of Carbon, Oxygen, Phosphorus, and Titanium. 
C) A second implant at 40X with surface delamination. D) Positive control under SEM 
at 1200X with the lack of surface delamination and normal bone-implant interface. 
 
 
 
Figure 5. Failed implant depicting titanium particles within bacterial colonies. A) 40X 
magnification portraying countless bacilli and titanium particles. B) 100X of the same 
region. Note the presence of numerous small titanium particles and bacilli. 
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Figure 6. Titanium debris of varying sizes observed using SEM. A) 30X magnification 
of a failed implant possessing titanium debris within the internal screw connection and 
along the external implant surface. B) 180X of the same failed implant portraying a large 
titanium particle. C) 750X of a failed implant possessing small titanium particles 
embedded in the surrounding soft tissue. D) Point EDS showing the presence of titanium 
at all points. Point 7 is made up of 46.29 % silicon, which was considered artifact from 
the glass slide. 
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Figure 7. A single failed implant that contains a micro fracture with the ingrowth of 
bacterial cocci. A) 180X magnification displaying the extent of the fracture and bacterial 
colonies. B) 750X magnification highlights a well-organized bacterial colony that has 
infiltrated the implant surface. C) EDS analysis of these same bacteria at 1100X. D) 
Results of EDS reveal the presence of titanium within the bacteria. Points 14 and 15 are 
the only areas with undetectable levels of titanium. 
 
 
